Lyme disease

Supporting evidence

• Evidence review

• Evidence reviews – April 2018

• A: Awareness of Lyme disease (PDF 359 KB)

  Published:

  11 April 2018

• B: Diagnostic accuracy of signs and symptoms (PDF 604 KB)

  Published:

  11 April 2018

• C: Diagnostic tests (PDF 2.33 MB)

  Published:

  11 April 2018

• C: Diagnostic tests – evidence tables (appendix D) (PDF 2.85 MB)

  Published:

  11 April 2018

• D: Management of erythema migrans (PDF 4 MB)

  Published:

  11 April 2018

• E: Management of non-specific symptoms related to Lyme disease (PDF 409 KB)

  Published:

  11 April 2018

• F: Management of neuroborreliosis (PDF 737 KB)

  Published:

  11 April 2018

• G: Management of Lyme arthritis (PDF 519 KB)

  Published:

  11 April 2018

• H: Management of acrodermatitis chronica atrophicans (PDF 566 KB)

  Published:

  11 April 2018

• I: Management of Lyme carditis (PDF 410 KB)

  Published:

  11 April 2018

• J: Management of lymphocytoma (PDF 400 KB)

  Published:

  11 April 2018

• K: Management of non-neurological ocular manifestations (PDF 405 KB)

  Published:

  11 April 2018

• L: Management of ongoing symptoms related to Lyme disease (PDF 866 KB)

  Published:

  11 April 2018

• M: Person-to-person transmission (PDF 415 KB)

  Published:

  11 April 2018

• N: Information needs (PDF 424 KB)

  Published:

  11 April 2018

• Other supporting evidence

• Methods (PDF 3.27 MB)

  Published:

  11 April 2018

• Acknowledgements (PDF 104 KB)

  Published:

  11 April 2018

• Membership of the guideline committee (PDF 368 KB)

  Published:

  11 April 2018